FDA Approved: CALCIPOTRIENE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for CALCIPOTRIENE from Prasco Laboratories. This action supplements the original NDA020554 for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• Calcipotriene (calcipotriene)

Snippet

SUPPL AP for CALCIPOTRIENE (CALCIPOTRIENE)